<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01435746</url>
  </required_header>
  <id_info>
    <org_study_id>TROLL11</org_study_id>
    <nct_id>NCT01435746</nct_id>
  </id_info>
  <brief_title>Transfusion Requirements After Orthotopic Liver Transplantation</brief_title>
  <acronym>TROLL</acronym>
  <official_title>A Randomized, Controlled Pilot Trial of Transfusion Requirements After Orthotopic Liver</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial is to evaluate different transfusion strategies in patients after
      liver transplantation. Patients in the experimental arm will be given red blood cell (RBC)
      transfusion according to a liberal strategy, i. e., transfusions should be given, when
      hemoglobin concentration falls below 10 g/dl, and hemoglobin concentration should be
      maintained between 10 and 12 g/dl. Patients in the control arm will be given red blood cell
      (RBC) transfusion according to a restrictive strategy, i. e., transfusions should be given,
      when hemoglobin concentration falls below 8 g/dl, and hemoglobin concentration should be
      maintained between 8 and 10 g/dl.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of death, graft loss and renal failure</measure>
    <time_frame>30 days after randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function</measure>
    <time_frame>30 days after randomization</time_frame>
    <description>Renal function will be assessed by estimated glomerular filtration rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>Liberal Transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the liberal transfusion group will receive red blood cell transfusions when their hemoglobin concentration drops below 10 g/dl. The aim should be to reach a hemoglobin concentration between 10 and 12 g/dl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative Transfusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the conservative transfusion group will receive red blood cell transfusions when their hemoglobin concentration drops below 8 g/dl. The aim should be to reach a hemoglobin concentration between 8 and 10 g/dl.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
    <description>The intervention of this trial is the regime of red blood cell transfusion. The control group will receive red blood cell transfusions according to a conservative regime, whereas the experimental group will receive red blood cell transfusion according to a liberal transfusion regime.</description>
    <arm_group_label>Liberal Transfusion</arm_group_label>
    <arm_group_label>Conservative Transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing liver transplantation

          -  Patients considered to have euvolemia after initial treatment by attending physicians

        Exclusion Criteria:

          -  Patients age 18 or less

          -  Patients undergoing combined liver-kidney transplantation

          -  Patients requiring renal replacement therapy before liver transplantation for longer
             than two weeks

          -  Inability to receive blood products

          -  Patient with active blood loss at the time of enrollment

          -  Pregnancy

          -  Imminent death
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Armin D Goralczyk, Dr.</last_name>
    <phone>+49 551 398490</phone>
    <email>agoralczyk@med.uni-goettingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aiman Obed, Prof.</last_name>
    <phone>+49 551 398490</phone>
    <email>aobed@med.uni-goettingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Göttingen</name>
      <address>
        <city>Göttingen</city>
        <state>Niedersachsen</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Armin D Goralczyk, Dr.</last_name>
      <phone>+49 551 398490</phone>
      <email>agoralczyk@med.uni-goettingen.de</email>
    </contact>
    <investigator>
      <last_name>Aiman Obed, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Lorf, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2011</study_first_submitted>
  <study_first_submitted_qc>September 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2011</study_first_posted>
  <last_update_submitted>September 16, 2011</last_update_submitted>
  <last_update_submitted_qc>September 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Armin Goralczyk</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>liver transplantation</keyword>
  <keyword>intensive care</keyword>
  <keyword>red blood cell transfusion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

